pharma · Ependymoma, Medulloblastoma · chronically occluded coronary artery
Ishita Pharma -
ISTA Pharma Limited
Ishita Pharma - trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Mumbai, IN HQ
3 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Employees
- 3
- Programs
- 8
- Drugs
- 19
- Patents
- 0
Ishita Pharma - clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Ishita Pharma - programs — each row shows trial ID, program name, phase, status, and indication.
Ishita Pharma - trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Ishita Pharma -.
-
Etude DAPT-CTO — Phase 3
Clinical update -
RCAPHM19_0374 — Phase 3
Clinical update -
RCAPHM18_0018 — Phase 3
Clinical update -
MICROPREP III — Phase 3
Clinical update -
MEPENDAX — Phase 2
Clinical update -
AUTOP 2 — Phase 3
Clinical update -
KVD900 150 mg — Phase 3
Clinical update -
NICOTINAMIDE, cellulose microcristalline — Phase 3
Clinical update